News

April 5, 2019

Be the Difference Foundation Brings ‘Wheel to Survive’ to Boulder, Colorado

News

To celebrate ovarian cancer survivors while raising funds for research and patient programs, the Be the Difference Foundation will present its signature “Wheel to Survive” event May 19 in Boulder, ... Read more

April 3, 2019

DPX-Survivac Treatment Continues to Show Promise in Women with Advanced Ovarian Cancer, Early Data Show

News

Treatment with DPX-Survivac plus intermittent low-dose cyclophosphamide continues to show promise in women with advanced recurrent ovarian cancer, the second part of a Phase 1/2 trial shows. Interim data from ... Read more

March 29, 2019

Phase 3 Trial Launched to Test TTFields-Taxol Combo on Platinum-resistant Ovarian Cancer

News

Novocure has initiated a Phase 3 trial investigating its Tumor Treating Fields (TTFields) — a method that uses electric fields to disrupt cell division — in combination with Taxol (paclitaxel) ... Read more

March 27, 2019

Patients with Platinum-sensitive Ovarian Cancer Live Longer on SOTIO’s Immunotherapy, Trial Shows

News

Adding SOTIO’s ovarian cancer immunotherapy DCVAC/OvCa to standard second-line chemotherapy significantly extends the lives of women with advanced ovarian cancer who initially responded to their first-line chemotherapy, a Phase 2 ... Read more

March 25, 2019

Uterine Fluid Analysis May Aid in Early Diagnosis of Aggressive OC

News

Proteomic analysis — the characterization of all proteins present in a cell at a given time — in liquid biopsies from the womb may facilitate the early diagnosis of women ... Read more

March 22, 2019

Low White Blood Cell Count May Help Predict Some Ovarian Cancer Outcomes

News

A reduced number of lymphocytes — one of the main types of immune cells — in advanced ovarian cancer patients before treatment is linked with a higher risk of disease ... Read more

March 20, 2019

Removing Lymph Nodes Does Not Improve Survival Outcomes of Advanced Ovarian Cancer Patients, Trial Shows

News

Women with advanced ovarian cancer who underwent a complete resection of their tumor and have normal lymph nodes do not have better survival outcomes if the lymph nodes surrounding the tumor ... Read more

March 18, 2019

GEN-1 Added to Chemo Shows Benefits in Newly Diagnosed Advanced OC

News

Adding Celsion‘s GEN-1 to standard chemotherapy — given prior to surgery — stops disease progression in patients with newly diagnosed advanced ovarian cancer and helps remove the tumor successfully during surgery, ... Read more

March 15, 2019March 15, 2019

Ultrasensitive Chip Detects Cancer Faster, Less Invasively than Current Approaches, Study Suggests

News

Researchers have developed an ultrasensitive diagnostic device, a kind of “lab-on-a-chip,” that quickly detects cancer using a droplet of blood, potentially allowing for an easier, cheaper, and more timely cancer diagnosis. ... Read more

March 13, 2019March 13, 2019

Researchers Find Compounds that Kill Chemo-resistant Cancer Cells

News

A new study reports the development of compounds that could be used as ovarian cancer treatment. These compounds are particularly promising because they may be able to affect cancer that ... Read more